ALA — Arovella Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$61.65m
- AU$47.30m
- AU$0.80m
Brief: Arovella Therapeutics Posts FY Total Comprehensive Loss For Year A$8.6 Million
Brief: Arovella Therapeutics Announces Sumatriptan Update
Brief: Arovella Therapeutics Says Paul Hopper Is Stepping Down As Non-Executive Chairman
Brief: Arovella Therapeutics Says It Agreed Commercial Terms For Manufacturing Services Agreement
Australia Stock Exchange release from AROVELLA THERAPE : Notice Under Section 708A
Australia Stock Exchange release from AROVELLA THERAPE : Notification regarding unquoted securities - ALA
Australia Stock Exchange release from AROVELLA THERAPE : Notification regarding unquoted securities - ALA
Australia Stock Exchange release from AROVELLA THERAPE : Application for quotation of securities - ALA
Australia Stock Exchange release from AROVELLA THERAPE : Application for quotation of securities - ALA
Australia Stock Exchange release from AROVELLA THERAPE : Proposed issue of securities - ALA
Australia Stock Exchange release from AROVELLA THERAPE : Change of Director's Interest Notice x5
Australia Stock Exchange release from AROVELLA THERAPE : Notice Under Section 708A
Australia Stock Exchange release from AROVELLA THERAPE : Application for quotation of securities - ALA
Australia Stock Exchange release from AROVELLA THERAPE : Application for quotation of securities - ALA
Australia Stock Exchange release from AROVELLA THERAPE : Results of General Meeting
Australia Stock Exchange release from AROVELLA THERAPE : Update - Proposed issue of securities - ALA
Australia Stock Exchange release from AROVELLA THERAPE : PRE_NR Ends: 10:11:21
Australia Stock Exchange release from AROVELLA THERAPE : Appendix 4D and Half Year Report
Brief: Arovella Therapeutics Received Subscriptions In Excess Of A$2.5 Mln Available Under SPP Offer